Hester Biosciences Limited released its earnings results on Nov 12, 2025. The company reported ₹16.985 earnings per share for the quarter, beating the consensus estimate of N/A by ₹16.985.

Is Hester Biosciences Limited overvalued?

According to Wall Street analysts Hester Biosciences Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Hester Biosciences Limited pay dividends?

Hester Biosciences Limited pays a Annually dividend of ₹7 which represents an annual dividend yield of 0.44%. See more information on Hester Biosciences Limited dividends here

What is Hester Biosciences Limited’s EPS estimate?

Hester Biosciences Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Hester Biosciences Limited have?

Hester Biosciences Limited has 8,506,865 shares outstanding.

What happened to Hester Biosciences Limited’s price movement after its last earnings report?

Hester Biosciences Limited reported an EPS of ₹16.985 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 3.102%.

Which hedge fund is a major shareholder of Hester Biosciences Limited?

Currently, no hedge funds are holding shares in IN:HESTERBIO

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Hester Biosciences Limited

Hester Biosciences Limited manufactures and trades in veterinary vaccines and animal health products in India and internationally. It operates in two segments, Poultry Healthcare and Animal Healthcare. The company provides poultry vaccines for diseases, such as newcastle disease, infectious bronchitis, infectious bursal disease, fowl pox, egg drop syndrome, reo, marek's disease, infectious coryza, fowl cholera, mycoplasma gallisepticum, inclusion body hepatitis, avian encephalomyelitis, etc. It also offers vaccines for large animals comprising Goat Pox, Peste des Petits Ruminants, Brucellosis, Mastitis, Metritis, and various infectious diseases, as well as infections, reproductive disorders, theileriosis, parasitic diseases, etc. In addition, the company provides feed supplements, such as toxin binder, trace minerals, enzyme preparation, and bypass fat; disinfectants for farms and equipment, and water sanitizers; nutrition products consisting of mineral mixtures, fertility supplements, and growth tonics; and herbal products, including growth promoters, herbal replacers for choline chloride, stress relievers and immunity boosters, respiratory stimulants, liver tonics, wound healing preparations, uterine tonics, digestive tonics and anti-bloat solutions, ectoparasiticide preparations, anti-mastitis, and anti-prolapse preparations. Hester Biosciences Limited was incorporated in 1987 and is headquartered in Ahmedabad, India.